Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant® and norethisterone enanthate injectable progestogen contraceptive users

Human Reproduction

Volumn 11, Issue SUPPL. 2, 1996, Pages 144-149

  Wonodirekso, Sugito ^a   Hadisaputra, Wachju ^a   Affandi, Biran ^a   Siregar, Budiningsih ^a   Rogers, Peter A W ^b  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cytokeratin; Endometrium; Epithelium; Norethisterone enanthate; Norplant

Indexed keywords

CYTOKERATIN; LEVONORGESTREL; NORETHISTERONE ENANTATE;

ADULT; BREAKTHROUGH BLEEDING; CONFERENCE PAPER; CONTRACEPTION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; MENSTRUAL CYCLE; PROTEIN EXPRESSION; UTERUS BLEEDING;

EID: 0030317419     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/11.suppl_2.144     Document Type: Article

References (20)

1. Au, C.L., Affandi, B. and Rogers, P.A.W. (1994) Immunohistochemical staining of von Willebrand factor in the endometrium of women during the first year of Norplant implant use. Contraception, 50, 477-489.
2. Bowmik, T. and Mukherjea, M. (1988) Histological changes in the ovary and uterus of rat after injectable contraceptive therapy. Contraception, 37, 529-538.
3. Critchley, H.O.D., Bailey, D.A., Au, C.L., Affandi, B. and Rogers, P.A.W. (1993) Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum. Reprod., 8, 1632-1639.
4. Gijbels, M.J.J., van der Ham, F., van Bennekum, A.M. and Roholl, P.J.M. (1992) Alteration in cytokeratin expression precedes histological changes in epithelia of vitamin A-deficient rats. Cell Tissue Res., 268, 197-203.
5. Goldman, R.D., Goldman, A., Green, K. et al. (1985) Intermediate filaments: possible functions as cytoskeletal connecting links between the nucleus and the cell surface. Ann. N.Y. Acad. Sci., 455, 1-17.
6. Goldman, R.D., Zackroff, R.V. and Steinert, P.M. (1990) Intermediate filaments: an overview. In Goldman, R.D. and Steinert, P.M. (eds), Cellular and Molecular Biology of Intermediate Filaments. Plenum Press, New York, NY, USA, pp. 3-15.
7. Green, K.J. and Jones, J.C.R. (1990) Interaction of intermediate filaments with the cell surface. In Goldman, R.D. and Steinert, P.M. (eds), Cellular and Molecular Biology of Intermediate Filaments. Plenum Press, New York, NY, USA, pp. 147-165.
8. Howard, G., Blair, M., Chen, J.K. et al. (1982) Clinical trial of norethisterone enanthate (Norigest) injected every two months. Contraception, 25, 333-340.
9. Howard, G., Blair, M., Fotherby, K. et al. (1986) Seven years clinical experience of the injectable contraceptive, norethisterone enanthate. Br. J. Fam. Plann., 11, 9-16.
10. Joshi, J.V., Hazari, K.T., Shah, R.S. et al. (1988) Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses. Steroid, 53, 751-761.
11. Nagle, R.B. (1989) Intermediate filaments. Am. J. Clin. Pathol., 94 (Suppl. 1), S14-S18.
12. Odlin, V. and Fraser, I.S. (1990) Contraception and menstrual bleeding disturbances: a clinical overview. In D'Arcangues, C., Fraser, I.S., Newton, J.R. and Odlin, V. (eds), Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, UK, pp. 5-29.
13. Ouhayoun, J.P., Goffaux, J.C., Sawaf, M.H. et al. (1990) Changes in cytokeratin expression in gingiva during inflammation. J. Periodont. Res., 25, 283-292.
14. Quinlan, R.A., Schiller, D.L., Hatzfeld, M. et al. (1985) Pattern of expression and organization of cytokeratin intermediate filaments, Ann. N.Y. Acad. Sci., 455, 282-306.
15. Rogers, P.A.W., Au, C.L. and Affandi, B. (1993) Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum. Reprod., 8, 1396-1404.
16. Skalli, O. and Gabbiani, G. (1990) Expression, organisation, and involvement of intermediate filaments in disease processes. In Goldman, R.D. and Steinert, P.M. (eds), Cellular and Molecular Biology of Intermediate Filaments. Plenum Press, New York, NY, USA, pp. 415-450.
17. Subakir, S.B., Hadisaputra, W., Siregar, B. et al. (1995) Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception. Hum. Reprod., 10, 2579-2583.
18. Topzada, M. (1983) Norethisterone (Norethindrone) enanthate, clinical study. In Zatuchni, G.L., Goldsmith, A., Shelton, J.D. and Sciara, J.J. (eds), Long-acting Contraceptive Delivery Systems. Harper and Row, Philadephia, PA, USA, pp. 502-514.
19. Tropey, N., Wylie, C.C. and Heasman, J. (1992) Function of maternal cytokeratin in Xenopus development. Nature, 357, 413-415.
20. Wonodirekso, S., Au, C.L., Hadisaputra, W., Affandi, B. and Rogers, P.A.W. (1993) Cytokeratin 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant. Contraception, 48, 481-493.